Potential Mechanism of the Anti-trypanosomal Activity of Organoruthenium Complexes with Bioactive Thiosemicarbazones
- 7 April 2013
- journal article
- research article
- Published by Springer Nature in Biological Trace Element Research
- Vol. 153 (1-3) , 371-381
Abstract
In the search for new metal-based drugs against diseases produced by trypanosomatid parasites, four organoruthenium(II) compounds [Ru2(p-cymene)2(L)2]X2, where L are bioactive 5-nitrofuryl-containing thiosemicarbazones and X = Cl or PF6, had been previously obtained. These compounds had shown activity on Trypanosoma brucei, the etiological agent of African trypanosomiasis. Because of genomic similarities between trypanosomatides, these ruthenium compounds were evaluated, in the current work, on Trypanosoma cruzi, the parasite responsible of American trypanosomiasis (Chagas disease). Two of them showed significant in vitro growth inhibition activity against the infective trypomastigote form of T. cruzi (Dm28c clone, IC50 = 11.69 and 59.42 μM for [Ru2(p-cymene)2(L4)2]Cl2 and [Ru2(p-cymene)2(L1)2]Cl2, respectively, where HL4 = 5-nitrofuryl-N-phenylthiosemicarbazone and HL1 = 5-nitrofurylthiosemicarbazone), showing fairly good selectivities toward trypanosomes with respect to mammalian cells (J774 murine macrophages). Moreover, [Ru2(p-cymene)2(L2)2]Cl2, where HL2 = 5-nitrofuryl-N-methylthiosemicarbazone, was synthesized in order to evaluate the effect of improved solubility on biological behavior. This new chloride salt showed higher activity against T. cruzi than that of the previously synthesized hexafluorophosphate one (Dm28c clone, IC50 = 14.30 μM for the former and 231.3 μM for the latter). In addition, the mode of antitrypanosomal action of the organoruthenium compounds was investigated. The complexes were not only able to generate toxic free radicals through bioreduction but they also interacted with two further potential parasite targets: DNA and cruzipain, a cysteine protease which plays a fundamental role in the biological cycle of these parasites. The results suggest a “multi-target” mechanism of trypanosomicidal action for the obtained complexes.Keywords
This publication has 48 references indexed in Scilit:
- Ruthenium–Arene Complexes of Curcumin: X-Ray and Density Functional Theory Structure, Synthesis, and Spectroscopic Characterization, in Vitro Antitumor Activity, and DNA Docking Studies of (p-Cymene)Ru(curcuminato)chloroJournal of Medicinal Chemistry, 2012
- New organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agentsDalton Transactions, 2011
- DNA as molecular target of analogous palladium and platinum anti-Trypanosoma cruzi compounds: A comparative studyJournal of Inorganic Biochemistry, 2011
- Neglected Tropical Diseases: Multi-Target-Directed Ligands in the Search for Novel Lead Candidates against Trypanosoma and LeishmaniaJournal of Medicinal Chemistry, 2009
- New, Improved Treatments for Chagas Disease: From the R&D Pipeline to the PatientsPLOS Neglected Tropical Diseases, 2009
- A short history of SHELXActa Crystallographica Section A Foundations of Crystallography, 2007
- Control of Neglected Tropical DiseasesNew England Journal of Medicine, 2007
- A Mild Pummerer-Like Reaction of Carbohydrate-Based Selenoethers and Thioethers Involving Linear Ozonide Acetates as Putative IntermediatesJournal of the American Chemical Society, 2005
- A comparative study of the interaction of two structurally analogue ruthenium(II) complexes with DNAJournal of Inorganic Biochemistry, 2004
- Synthesis and Structure−Activity Relationships of Parasiticidal Thiosemicarbazone Cysteine Protease Inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruziJournal of Medicinal Chemistry, 2004